Sign inJoin waitlistJoin the waitlist

John Poulos

Physician · Cape Fear Valley Health System

Credentials: · · ·

History

Cape Fear Valley Health System
2022–Present

Gastroenterology
St Louis Univ Sch of Med
1994–1997
Internal Medicine
University of South Florida Morsani College of Medicine
1991–1994
The Brody School of Medicine at East Carolina University
1987–1991

Research

Insulin-like growth factor I binding in hepatocytes from human liver, human hepatoma, and normal, regenerating, and fetal rat liver
Journal of Clinical Investigation · 1988 · 264 citations
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH
Hepatology · 2021 · 250 citations
Repetitive self-limited acute pancreatitis induces pancreatic fibrogenesis in the mouse
Digestive Diseases and Sciences · 2000 · Last of 9 authors · 94 citations

BB
Bruce Bacon
5 papers
DV
David Vesely
5 papers
Adrian Di Bisceglie
3 papers
Kris Kowdley
3 papers
MP
Michael Presti
3 papers
AS
Aasim Sheikh
2 papers
Brent Tetri
2 papers
Elizabeth Brunt
2 papers
HF
Hector Fontanet
2 papers
JM
John McHutchison
2 papers
Mazen Noureddin
2 papers
Mitchell Shiffman
2 papers

Clinical trials

Study to Evaluate the Effect of RGMA001 on Patients With Non Alcoholic Fatty Liver Disease (NAFLD)
Principal investigator · Unknown
Biovil Research Group, LLC
2012
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
Site PI · Recruiting · Phase 3
GlaxoSmithKline
2025–2031
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2028
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Site PI · Recruiting · Phase 3
Eli Lilly and Company
2025–2028